Oramed Pharmaceuticals Inc.

ORMP

$4.93

-2.76%

N/A-$0.14

Healthcare

Biotechnology

NASDAQ

Active Trading

Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their ...

Insider Transactions of ORMP

Acquisitions (A)

Since Mar 17, 2026

Disposals (D)

Since Mar 17, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jul 2, 2026	Hexter Joshua	officer: COO & CBO	Common Stock	A	50,000	$3.69
Jul 2, 2026	Hexter Joshua	officer: COO & CBO	Stock option (right to buy)	D	50,000	$3.69
Jul 1, 2026	Hexter Joshua	officer: COO & CBO	Common Stock	D	137,000	$4.46
Jul 1, 2026	Gabay Avraham	officer: Chief Financial Officer	Common Stock	D	73,360	$4.51
Mar 30, 2026	KIDRON NADAV	director, officer: President and CEO	Common Stock	D	44,818	$3.31

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

528,341

Total Shares Sold

740,262

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

KIDRON NADAV

director, officer: President and CEO • 2 txns

Hexter Joshua

officer: COO & CBO • 4 txns

Gabay Avraham

officer: Chief Financial Officer • 2 txns

Kidron Miriam

director, officer: Chief Scientific Officer • 2 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jul 2, 2026	Hexter Joshua	officer: COO & CBO	Common Stock	A	50,000	$3.69	$184,500.00
Jul 2, 2026	Hexter Joshua	officer: COO & CBO	Stock option (right to buy)	D	50,000	$3.69	$184,500.00
Jul 1, 2026	Hexter Joshua	officer: COO & CBO	Common Stock	D	137,000	$4.46	$611,431.00
Jul 1, 2026	Gabay Avraham	officer: Chief Financial Officer	Common Stock	D	73,360	$4.51	$330,743.56
Mar 30, 2026	KIDRON NADAV	director, officer: President and CEO	Common Stock	D	44,818	$3.31	$148,347.58
Mar 30, 2026	Kidron Miriam	director, officer: Chief Scientific Officer	Common Stock	D	435,084	$3.31	$1,440,128.04
Mar 17, 2026	Kidron Miriam	director, officer: Chief Scientific Officer	Common Stock	A	119,558	—	—
Mar 17, 2026	KIDRON NADAV	director, officer: President and CEO	Common Stock	A	167,005	—	—
Mar 17, 2026	Hexter Joshua	officer: COO & CBO	Common Stock	A	95,889	—	—
Mar 17, 2026	Gabay Avraham	officer: Chief Financial Officer	Common Stock	A	95,889	—	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer